Meissa Vaccines Inc — Form D
Meissa Vaccines Inc of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-16. The offering totals $5.0M, of which $1.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-10-16
- Form: D
- Accession: 0001719789-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.2M
- Remaining: $3.8M
- Investors: 14
- Date of first sale: 2016-07-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-296811
Issuer
- Name: Meissa Vaccines Inc
- CIK: 0001719789
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 329 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-356-0494
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Roderick Tang | Director | South San Francisco, CA |
| Martin Moore | Promoter | South San Francisco, CA |
| Roderick Tang | Promoter | South San Francisco, CA |
| Isaac Cheng | Director | Portland, ME |
| Martin Moore | Director | South San Francisco, CA |
| Martin Moore | Executive Officer | South San Francisco, CA |
| Kenneth Kelley | Director | South San Francisco, CA |
| Stephanie O?Brien | Director | South San Francisco, CA |
| William Daly | Director | South San Francisco, CA |
| Roderick Tang | Executive Officer | South San Francisco, CA |
Other filings by this issuer (1)
More